Psychology Faculty Publications

Psychology

8-15-2019

Patterns of Treatment for Psychiatric Disorders Among Children
and Adolesecents in Mississippi Medicaid
John Young
University of Mississippi, jnyoung1@olemiss.edu

Sujith Ramachandran
Univesity of Mississippi

Andrew J. Freeman
University of Nevada, Las Vegas, andrew.freeman@unlv.edu

John P. Bentley
University of Mississippi

Benjamin F. Banahan
University of Mississippi
Follow this and additional works at: https://digitalscholarship.unlv.edu/psychology_fac_articles
Part of the Health Services Research Commons, and the Psychiatric and Mental Health Commons

Repository Citation
Young, J., Ramachandran, S., Freeman, A. J., Bentley, J. P., Banahan, B. F. (2019). Patterns of Treatment for
Psychiatric Disorders Among Children and Adolesecents in Mississippi Medicaid. PLOS ONE 1-12. Public
Library of Science.
http://dx.doi.org/10.1371/journal.pone.0221251

This Article is protected by copyright and/or related rights. It has been brought to you by Digital Scholarship@UNLV
with permission from the rights-holder(s). You are free to use this Article in any way that is permitted by the
copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from
the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/
or on the work itself.
This Article has been accepted for inclusion in Psychology Faculty Publications by an authorized administrator of
Digital Scholarship@UNLV. For more information, please contact digitalscholarship@unlv.edu.

RESEARCH ARTICLE

Patterns of treatment for psychiatric
disorders among children and adolescents in
Mississippi Medicaid
John Young ID1*, Sujith Ramachandran2, Andrew J. Freeman3, John P. Bentley2,
Benjamin F. Banahan2
1 Department of Psychology, University of Mississippi, Oxford, MS, United States of America, 2 Department
of Pharmacy Administration, University of Mississippi, Oxford, MS, United States of America, 3 Department
of Psychology, University of Nevada, Las Vegas, NV, United States of America

a1111111111
a1111111111
a1111111111
a1111111111
a1111111111

OPEN ACCESS
Citation: Young J, Ramachandran S, Freeman AJ,
Bentley JP, Banahan BF (2019) Patterns of
treatment for psychiatric disorders among children
and adolescents in Mississippi Medicaid. PLoS
ONE 14(8): e0221251. https://doi.org/10.1371/
journal.pone.0221251
Editor: Satya Surbhi, University of Tennessee
Health Science Center, UNITED STATES
Received: February 15, 2019
Accepted: August 4, 2019
Published: August 15, 2019
Copyright: © 2019 Young et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The data used in this
study were accessed through a data use
agreement with a third party owner (Mississippi
Division of Medicaid). Other researchers interested
in applying for similar access can follow
procedures given at the Division of Medicaid
website (https://medicaid.ms.gov/contact/
requests-for-information/).
Funding: The authors received no specific funding
for this work.

* jnyoung1@olemiss.edu

Abstract
The nature of services for psychiatric disorders in public health systems has been understudied, particularly with regard to frequency, duration, and costs. The current study examines patterns of service reception and costs among Medicaid-covered youth newly
diagnosed with anxiety, depression, or behavioral disturbance in a large data set of provider
billing claims submitted between 2015–2016. Eligibility criteria included: 1) identification of
an initial diagnosis of a single anxiety, unipolar mood, or specific behavioral disorder; 2) continuous Medicaid eligibility over the duration of the time period studied; and 3) under 18
years of age on the date of initial psychiatric diagnosis. The final cohort included 7,627
cases with a mean age of 10.65 (±4.36), of which 58.04% were male, 57.09% were Black,
38.97% were White, and 3.95% were of other ethnicities. Data indicated that 65.94% of the
cohort received at least some follow-up services within a median 18 days of diagnosis. Of
those, 54.27% received a combination of medical and psychosocial services, 32.01%
received medical services only, and 13.72% received psychosocial services only. Overall
median costs for direct treatment were $576.69, with wide discrepancies between the lowest
(anxiety = $308.41) and highest (behavioral disturbance = $653.59) diagnostic categories.
Across all categories the frequency and duration of psychosocial services were much lower
than would be expected in comparison to data from a well-known effectiveness trial. Overall,
follow-up to psychiatric diagnosis could be characterized as highly variable, underutilized,
and emphasizing biomedical treatment. Understanding more about these patterns may
facilitate systematic improvements and greater cost efficiency in the future.

Introduction
Mental health disorders are prevalent in children and adolescents [1–4] and often exhibit a
chronic course without intervention [5–7]. Youth who experience psychopathology have more
negative life outcomes such as poor school performance, involvement with child welfare or
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juvenile justice systems, and illicit substance use than typically developing youth [8]. Unfortunately, fewer than 1 in 4 afflicted youth receive services [9], potentially at least partly due to
mental health treatment being stigmatized [9,10] and limited accessibility (particularly in
terms of evidence-based treatments [7,11–21]). The mismatch between those in need and
those receiving services is unfortunate given that numerous psychosocial treatments for youth
have accumulated empirical support in a wide range of service settings [22–27].
Explanations for why youth fail to intersect with appropriate services are complex, multifaceted, and presently unclear. Economic factors, shifting policies toward mental health parity,
expansion of Medicaid coverage, and adaptation to the Affordable Care Act (ACA [28,29])
have all increased the potential for adequate mental healthcare for youth. The provision of evidence-supported mental healthcare, however, appears to be both limited in prevalence and
duration and becoming less common over time [30–32]. Despite widely disseminated practice
guidelines calling for psychosocial interventions as primary interventions, the majority of clinicians report infrequent use of evidence-supported treatment strategies [33–37]. Instead, prescription medication as the sole treatment approach for psychiatric symptoms has been
increasing, even in contexts where evidence for these approaches is mixed or lacking entirely
[38, 39].
The reasons for this trend in service provision are not clear, and previous studies using
cross-sectional, random samples of the national patient population to examine the issue do not
provide elucidation [31]. This methodology provides insight into generalities about the US
mental health system overall, but potentially ignores evidence that healthcare utilization patterns differ substantially on the basis of ethnicity, geographic location, and other social factors
[32,40–42]. More localized, longitudinal examinations of the types, patterns, and costs of services received for psychiatric conditions would advance contemporary understanding in this
domain.
The current study utilizes secondary data from the Mississippi Division of Medicaid, which
included all child and adolescent billing claims submitted during a contiguous two-year
period. Specifically, longitudinal service patterns related to identifiable psychiatric diagnoses
were examined and broadly categorized as medical office visits only, psychosocial treatment
only, or combined treatment. The primary purpose of the current manuscript was to understand more about the typical form of service provision, including provider type, time between
meetings, treatment duration, and costs.

Methods
Data source
Data were sourced from all Mississippi Medicaid claims submitted between January 1, 2015
and December 31, 2016. Databases examined included files detailing beneficiary demographics, provider information, and all pharmacy, outpatient, medical, and inpatient claims submitted for billing. All statistical analyses were conducted with SAS 9.4 (SAS Institute, Cary, NC).
The project was approved by the University of Mississippi Institutional Review Board and the
data were accessed after approval from the Mississippi Division of Medicaid Privacy Board.

Inclusion & exclusion criteria
Study participants were required to be continuously eligible in Mississippi Medicaid for the
duration of the study period. Beneficiaries were included in the data set if they were newly
diagnosed with a psychiatric disorder from one of the following categories: anxiety, unipolar
depression, or a specific behavioral disturbance (i.e., conduct disorder or oppositional defiant
disorder). These general categories were utilized to allow direct comparisons of the patterns of
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Table 1. Demographic and diagnostic profile on index date.
Diagnosis
Anxiety

Depression

Behavioral Disturbance

Total n (%)

1888 (24.75)

1088 (14.27)

4651 (60.98)

Overall
7627

Female n (%)

1028 (54.45)

687 (63.14)

1485 (31.93)

3200 (41.96)

Age M (SD)

9.60 (5.10)

14.13 (2.77)

10.27 (3.92)

10.65 (4.36)

Race/Ethnicity n (%)
Black

794 (42.06)

561 (51.56)

2999 (64.48)

4354 (57.09)

White

987 (52.28)

484 (44.49)

1501 (32.27)

2972 (38.97)

Other

107 (5.67)

43 (3.95)

151 (3.25)

301 (3.95)

https://doi.org/10.1371/journal.pone.0221251.t001

psychosocial service utilization seen in the current data to the MacArthur Child STEPs project
(a well-known randomized clinical effectiveness trial [25] that included details about the frequency and timing of psychosocial treatments). Specific ICD codes for diagnoses comprising
each category appear in the S1 Appendix.
All participants’ records were identified using ICD-9 or -10 diagnostic codes present in the
outpatient, inpatient, or medical claims file (Table 1) between July 1st, 2015 and December
31st, 2015. An index date (i.e., date of initial diagnosis) was established within this time frame
for all cases meeting inclusionary criteria. Diagnoses were verified as new by examining data
from January 1, 2015 through June 30, 2015 to ensure that no earlier claims included reference
to the diagnosis of interest. In instances where the identified diagnosis was present between
January and June, 2015, the case was excluded from the study. Similarly, any indication of psychiatric comorbidity during this 6-month lookback period led to exclusion. Finally, beneficiaries were also excluded if they were 18 years of age or older on the index date. All cases
retained for study thus included at least 12 months of continuous data between the index date
and the end of the range represented in the data (December 31st, 2016).
Although these inclusionary criteria are somewhat restrictive, they allow for a detailed view
of services rendered for a focal problem type. There is also previous evidence to suggest that
intake assessments in the course of community-based clinical services result in assignment of a
single diagnosis [43]. The procedures employed were thus likely to result in cases with diagnostic profiles similar to what would be encountered in other public healthcare systems when
considering these problem types.

Outcome measures
The frequency of follow-up medical office visits and psychosocial service visits, time to initial
follow up, duration of treatment, specialties of the diagnosing and treating providers, and costs
for services were recorded for all beneficiaries in the final data set. These were compiled by
first identifying all claims for a given individual that included the relevant psychiatric diagnostic code. Among this set, those that contained CPT codes identifying a psychosocial service
(90832, 90834, 90837, 90846, 90847, 90791, 90853, 96101, 96111, 90618, H2012, 90785, 96127,
96110) were defined as psychosocial visits. Any claims beyond the index date that referenced
the initial psychiatric diagnosis but did not contain one or more of these CPTs were labeled as
follow-up medical office visits.
All study participants were classified as receiving either follow-up medical office visits only,
psychosocial services only, both medical office visits and psychosocial services (i.e., combined
treatment), or neither (i.e., the diagnosis of interest did not appear after the index date). For
any beneficiaries receiving services beyond the initial diagnosis, the time between the index
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date and the next identified service (regardless of type) was defined as the time to initial follow
up. Duration of treatment was defined as the time between the index date and the last followup medical office visit or psychosocial service during the study period.
Provider specialties were obtained from the National Provider Identifier (NPI) number
associated with each claim. The self-reported nature of NPIs produced a diverse array of data
describing clinical specialties, some of which referred to institutions and some to individuals.
For ease of interpretation, NPI numbers were therefore classified as belonging to one of the
following categories: General Medical Clinic or Hospital (GMCH), Inpatient Hospitalization
(INPT), Mental Health Practitioner (MHPR), Non-Mental Health Practitioner (NMPR),
Nurse Practitioner or Physician Assistant (NPPA), Psychologist (PSYO), Psychiatrist (PSYR),
Social Services (SOCS), Occupational Therapist (OCTR), Other (OTHR), or unknown
(UNKW).
The beneficiary demographics file was used to record the beneficiary’s age on the index
date, gender, and ethnicity. Data for costs of follow-up treatment were compiled using Mississippi Medicaid’s reimbursement rate for each CPT code for the appropriate fiscal year, which
yielded specific expenditures for services. It should be noted, however, that these calculations
did not include the cost of prescription drugs (given that it was impossible to connect medications to a specific diagnosis or medical office visit). The economic data that follow are thus representative of direct provider service costs only.
Finally, the patterns of service reception for each diagnostic category were compared to
those noted in the MacArthur Child STEPs treatment effectiveness study [25], which indicated
that individuals randomly assigned to manualized treatments received a mean of 16.17 (±9.95)
sessions separated by an average of 11.96 (±4.65) days. Given that this trial demonstrated superior outcomes for manualized approaches delivered in applied settings, these figures provide a
convenient means of comparing real-world patterns of service utilization to what might reasonably be expected if evidentiary services were being provided. The current data set was thus
examined in terms of the frequency of individuals who 1) received a number of psychosocial
sessions within one standard deviation of the MacArthur mean; 2) exhibited a pattern of timing between sessions within one standard deviation of the MacArthur mean; and 3) met both
of these criteria.

Results
Participants
The selection process resulted in a cohort of 7,627 individuals who were predominantly male
(58.04%) with a mean age of 10.65 (±4.36). Ethnic composition of this group was as follows:
57.09% Black (n = 4,354); 38.97% White (n = 2,972); 3.95% Other (n = 301). Table 1 reports
diagnoses by demographic categories, which were significantly different as a function of both
ethnicity (χ2 (4) = 292.86; p <0.0001) and gender (χ2 (2) = 513.59; p < 0.0001).

Initial diagnosis
As seen in Table 2, the most common provider type associated with initial psychiatric diagnosis was MHPR (31.18%), which included counselors and clinical social workers (but not psychologists or psychiatrists, each of which had its own category). The next-most frequent
provider type was NMPR, which primarily comprised physicians with a specialty other than
psychiatry (22.62%). Considered in combination with the frequencies attributable to GMHCs
(16.06%) or NPPAs (6.99%), it appears that roughly half of initial diagnoses were rendered in
non-specialized medical settings. Alternatively, diagnosis by a psychologist (6.08%) or psychiatrist (2.05%) was fairly rare. The rates of provider types also differed by diagnostic category,
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Table 2. Diagnosis and treatment provider type.
Provider Type–Initial Diagnosis
Diagnosis

Total n

GMCH

INPT

NMPR

NPPA

OCTR
& OTHR

PSYO

PSYR

SOCS

MHPR

UNKW

Anxiety
n (%)

1886

679 (36.00)

6
(0.32)

533
(28.26)

182 (9.65)

31
(1.64)

58
(3.08)

31
(1.64)

69
(3.66)

151
(8.01)

146
(7.74)

Depression
n (%)

1086

142 (13.08)

56
(5.16)

194
(17.86)

98 (9.02)

21
(1.93)

79
(7.27)

42
(3.87)

44
(4.05)

331 (30.48)

79
(7.27)

Behavioral Disorder
n (%)

4641

402 (8.66)

220
(4.74)

995
(21.44)

252 (5.43)

179
(3.86)

326
(7.02)

83
(1.79)

166
(3.58)

1892
(40.77)

126
(2.71)

Overall
n (%)

7613

1223 (16.06)

282
(3.70)

1722 (22.62)

532 (6.99)

231
(3.04)

463
(6.08)

156
(2.05)

279
(3.66)

2374 (31.18)

351
(4.61)

Diagnosis

Total n

GMCH

INPT

NMPR

NPPA

OCTR
& OTHR

PSYO

PSYR

SOCS

MHPR

UNKW

Anxiety
n (%)

688

81 (11.77)

3
(0.44)

158
(22.97)

82 (11.92)

21
(3.05)

54 (7.85)

31
(4.51)

59 (8.58)

141 (20.49)

58
(8.43)

Depression
n (%)

769

46 (5.98)

14
(1.82)

91
(11.83)

36 (4.68)

16
(2.08)

73 (9.49)

81 (10.53)

33 (4.29)

302 (39.27)

77
(10.01)

Behavioral Disorder
n (%)

3564

132 (3.70)

54
(1.52)

601
(16.86)

100 (2.81)

202
(5.67)

228 (6.40)

196
(5.50)

180
(5.05)

1757
(49.30)

114
(3.20)

Overall
n (%)

5021

259 (5.16)

71 (1.41)

850
(16.93)

218 (4.34)

239
(4.76)

355 (7.07)

308 (6.13)

272 (5.42)

2200 (43.82)

249
(4.96)

Provider Type–Follow-Up Treatment

Abbreviations: GMCH, General Medical Clinic or Hospital; INPT, Inpatient Hospitalization; NMPR, Non-Mental Health Practitioner; NPPA, Nurse Practitioner or
Physician Assistant; OCTR, Occupational Therapist; OTHR, Other; PSYO, Psychologist; PSYR, Psychiatrist, SOCS, Social Services; MHPR, Mental Health Practitioner;
UNKW, Unknown
Note: The group sizes in this table do not correspond to the overall number of participants due to provider NPI being missing from some billing claims. These cases
were separated from the “unknown” category given qualitative differences in these groups (i.e., unable to discern professional specialty from existing NPI and provider
self-description vs. information entirely absent).
https://doi.org/10.1371/journal.pone.0221251.t002

with medical/hospital facilities more likely to be the source of initial anxiety diagnoses and
mental health practitioners more likely to provide diagnoses of depression and behavioral
disturbance.

Follow-up services
Approximately two-thirds (65.94%) of beneficiaries received services beyond their initial diagnosis (Table 3). Among these, the median time to first follow-up visit was 18 days, although
the amount of delay was variable depending on diagnostic category (Table 4). Youth with
depression or behavioral disturbances were seen fairly quickly with median delays of 14 and 16
days (respectively), but the same statistic for youth with anxiety was 30 days. These times
Table 3. Number of youth receiving follow-up services by diagnosis and service type.
Diagnosis

Medical Office Only
n (%)

Psychosocial Only
n (%)

Medical Office & Psychosocial
n (%)

Neither
n (%)
1198 (63.45)

Anxiety

371 (19.65)

115 (6.09)

204 (10.81)

Depression

236 (21.69)

116 (10.66)

417 (38.33)

319 (29.32)

Behavioral Disorder

1003 (21.57)

459 (9.87)

2108 (45.32)

1081 (23.24)

Overall

1610 (21.11)

690 (9.05)

2729 (35.78)

2598 (34.06)

Note: Percentages are row percentages.
https://doi.org/10.1371/journal.pone.0221251.t003
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Table 4. Duration in days to initial follow-up visit among those receiving any services after diagnosis.
Overall

Medical Office Only

Psychosocial Only

Medical Office & Psychosocial

Diagnosis

Mean
(SD)

Median

n

Mean
(SD)

Median

n

Mean
(SD)

Median

n

Mean
(SD)

Median

n

Anxiety

88.83
(121.23)

30

690

123.16
(137.61)

66

371

36.50
(60.60)

21

115

55.89
(92.26)

15

204

Depression

51.25
(89.79)

14

769

93.43
(123.23)

34

236

41.11
(70.35)

17.5

116

30.20
(58.80)

11

417

Behavioral Disorder

49.82
(82.83)

16

3570

90.28
(110.43)

38

1003

43.15
(73.78)

38

459

32.03
(59.44)

11

2108

Overall

55.39
(91.07)

18

5029

98.32
(119.80)

42

1610

41.70
(71.12)

16

690

33.53
(62.69)

11

2729

https://doi.org/10.1371/journal.pone.0221251.t004

varied substantially, however, as a function of the type of follow-up services, with longer delays
notable in groups that received medical office visits as their sole form of treatment. Additionally, when examining the rates of follow-up by age group it was apparent that children age 6
and younger received additional services significantly less often (40.1%) than those ages 7–12
(70.3%) and 13–17 (73%).
Among those receiving follow-up services, youth were less likely to receive follow-up visits
through GMCH (5.16%) or NMPR (16.93%) in comparison to initial diagnoses. Psychologists
(7.07%), psychiatrists (6.13%), and other mental health practitioners (43.82%), however, represented a larger percentage of follow-up than initial visits, perhaps reflective of referral to these
professionals by less specialized providers. Similar to the data for initial diagnoses, there was
also variability in the percentage of provider types across categories (see Table 2).
Of the youth who received follow-up services (n = 5,029), more than half received a combination of medical office and psychosocial services (54.27%), one-third received medical office
visits only (32.01%), and the remainder received psychosocial services as their sole means of
treatment (13.72%). Youth with anxiety were least likely to receive any follow-up services
(36.55%), whereas the frequency of youth with depression (70.68%) or behavioral disturbances
(76.76%) receiving at least some treatment was approximately twice as high. Finally, youth
receiving combined treatment registered more psychosocial visits (18.39±29.70) than those
receiving psychosocial services alone (8.18±16.55).
Comparison of the group receiving any follow-up services to those who received none indicated significant differences in several demographic categories. Specifically, the no follow-up
group had a larger percentage of females (46.8% vs. 39.4%) different distribution of ethnicities
(Black: 49.8% vs. 60.9%; White: 45.6% vs. 35.6%; Other: 4.7% vs. 3.6%), and was younger
(mean 9.4 years of age ±4.8 vs 11.32±3.9; all ps < 0.0001). Additionally, these groups differed
significantly in terms of the type of provider assigning the original diagnosis. The most common type for the no follow-up group was non-mental health practitioners (35.2%), whereas in
the group that received subsequent services mental health practitioners were the most frequent
(43.0%).

Service costs
Costs of treatment were examined using all charges associated with any billing claim beyond
the initial diagnosis that included the psychiatric diagnosis of interest. The median cost of
treatment per individual receiving any follow-up services was $576.69. This amount differed
substantially by category from a low of $308.41 for anxiety to a high of $653.59 for behavioral
disturbances. Dividing these costs further by diagnostic category and provider type, it was
apparent that combined treatment was consistently more costly (i.e., between 200–600%
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Table 5. Direct service costs by category for cases receiving services beyond initial diagnosis (excluding pharmacy costs).
Average Cost Per Non-Zero Beneficiary in US Dollars
Diagnosis

Number of Beneficiaries

Overall Cost

Medical Office Only

Mean
(SD)

Median

Mean
(SD)

Median

Psychosocial Only

Medical Office &
Psychosocial

Mean
(SD)

Median

Mean
(SD)

Median
762.18

Anxiety

636

733.44 (1257.18)

308.41

432.37 (960.39)

180.80

560.36 (799.28)

274.16

1346.72 (1638.08)

Depression

727

1372.02 (3244.52)

580.61

680.39 (3507.85)

247.22

668.25 (1271.20)

265.73

1906.74 (3337.38) 1140.87

Behavioral Disorder

3450

2342.91 (7650.04)

653.59

2056.44 (11613.33)

231.72

749.72 (1572.80)

266.46

2801.55 (5933.51) 1335.57

Overall

4813

1983.58 (6640.70)

576.69

1487.78 (9336.02)

219.56

706.17 (1428.89)

266.04

2559.37 (5420.46) 1233.07

Note: The number of beneficiaries in this table does not correspond to the total number receiving services beyond initial diagnosis in Table 3, given that a number of
individuals had follow-up services that were billed to Medicaid but not reimbursed. The data in this table represent only those cases for which reimbursement occurred
(in an attempt to present typical capitated expenditures by the payer system for a given condition, as opposed to providers’ realized payments).
https://doi.org/10.1371/journal.pone.0221251.t005

higher within-category median expenditures than either of the other treatment types; see
Table 5).

Patterns of utilization
Among individuals receiving any psychosocial follow-up services, 1,187 received a total number of sessions within one standard deviation of the MacArthur mean (34.71% of the group
receiving follow-up psychosocial services). A similar examination for the amount of elapsed
time between sessions indicated that 83 individuals were within one standard deviation of the
MacArthur mean (2.43%). Only 14 cases met both criteria when examining their patterns of
service utilization (0.41%). For additional details about these patterns as a function of diagnostic category, please see Tables 6 and 7.

Discussion
The current study examined patterns of psychiatric diagnosis and treatment in a large cohort
of state-level child and adolescent Medicaid claims data over a two-year period. Approximately
two-thirds of individuals with a formal mental health diagnosis received some follow-up services, which exceeded commonly cited base rates in the literature (between approximately 12–
50% [44,45]). Initial diagnoses appear to have been rendered primarily in medical environments, but follow-up treatment occurred disproportionately in settings that were more focused
on treatment of psychiatric symptoms. Although the reasons for this observation are not clear,
one possibility is that diagnosing providers referred youth to specialized providers (consistent
with the intended framework of an integrated system of care). Regardless, it was also apparent
that psychosocial services were not typically emphasized as front-line treatments, despite
Table 6. Number of psychosocial services rendered.
Diagnosis

Overall
Mean (SD)

Psychosocial Only
Mean (SD)

Medical Office & Psychosocial
Mean (SD)
12.54 (18.46)

Anxiety (n = 319)

4.83 (12.40)

6.71 (11.66)

Depression (n = 533)

8.28 (26.97)

7.74 (17.51)

13.11 (17.82)

Behavioral
Disorder (n = 2567)

12.92 (26.97)

8.65 (17.33)

20.00 (32.15)

Overall (n = 3419)

11.10 (24.19)

8.18 (16.55)

18.39 (29.70)

https://doi.org/10.1371/journal.pone.0221251.t006
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Table 7. Duration of psychosocial services in weeks.
Diagnosis

Overall
Mean (SD)

Psychosocial Only
Mean (SD)

Medical Office & Psychosocial
Mean (SD)
40.26 (22.35)

Anxiety (n = 319)

33.60 (23.48)

21.77 (20.67)

Depression (n = 533)

37.51 (22.89)

22.63 (20.60)

41.65 (21.77)

Behavioral
Disorder (n = 2567)

35.91 (23.25)

19.77 (19.18)

39.42 (22.57)

Overall (n = 3419)

35.95 (23.22)

20.59 (19.68)

39.83 (22.44)

https://doi.org/10.1371/journal.pone.0221251.t007

strong evidence for the effectiveness of these techniques. The reasons for this outcome were
also unclear, although it is similar to other national administrative claims research and a trend
toward intervention through medication. One possible explanation is that the limited density
of psychosocial providers in a primarily rural, underserved state made it very difficult to find
and regularly receive services. Similarly, family financial limitations could have resulted in
additional difficulties. The likelihood of both of these issues simultaneously being present was
also very high, which could have resulted in effectively impassable barriers to receiving appropriate psychosocial care. In turn, such conditions could have facilitated decisions to pursue
more widely available psychotropic interventions (independent of family preferences).
Additionally, it was notable that patterns of service utilization were extremely variable as a
function of both diagnostic category and type of services received. For example, the rate of
individuals seeking treatment for anxiety was approximately half that of the other diagnoses,
and their delay in initial follow-up was nearly twice as long. Similarly, psychosocial services
were both more likely and more frequent for behavioral disturbance, and the frequency of
medical consultation was highest for cases of depression. Although these data may appear chaotic in overview, general trends did emerge (which could potentially facilitate the application
of similar techniques to other administrative claims databases).
Independent of trends in service provision, data on economic expenditures suggested wide
discrepancies depending upon the category of services received. Unsurprisingly, combined
treatment was typically substantially more costly than psychosocial or medical office visits
only. These services were also provided over a longer period of time with limited indication
that they more closely matched patterns likely to be consistent with evidentiary treatment.
More generally, resources expended for treatment across all categories (psychosocial or otherwise) were limited on a capitated basis. Given the possibility of exponentially escalating healthcare costs associated with psychiatric diagnosis over the course of an individual’s lifetime,
under-treating current symptoms could result in much higher expenditures in the future. At
the same time, data on current costs for psychosocial treatment can also be conceptualized as
infinitely high, given that the patterns of services observed were inconsistent with evidentiary
treatment in comparison to a known standard derived from work conducted in applied settings. The return on investment for these resources in terms of promoting individual health,
longevity, productivity, or adjustment is therefore potentially minimal, and the long-term
effectiveness of the system paying for these services is not enhanced as a result.
Future assessment of individual decision-making surrounding psychiatric diagnosis and
treatment could provide greater insights, which in turn could lead to better adaptations of evidence-supported treatments to a wide range of settings. In particular, exploration of longitudinal administrative claims data or other large data repositories may shed light on trajectories of
behavior subsequent to psychiatric diagnosis and discern predictors of specific paths (e.g., no
treatment vs. pharmacotherapy vs. psychosocial treatment, etc.). Emphasis on individual, longitudinal, ethnographic research may also contribute to understanding how people orient to

PLOS ONE | https://doi.org/10.1371/journal.pone.0221251 August 15, 2019

8 / 12

Psychiatric disorders in Medicaid

these problems and seek solutions for their healthcare needs, and how providers/healthcare
service provision networks may optimize outcomes.
Observations such as those outlined above with regard to anxiety (made using passively collected administrative claims data and techniques that could easily be automated) could also be
useful to facilitate service enhancement through the application of behavioral economic techniques [46,47]. Knowing that the base rate of treatment for symptoms of anxiety is low and the
delay to follow-up is long could confer the opportunity to provide newly diagnosed families
with behavioral nudges [48]. For example, indicating that 50% of people diagnosed with conditions other than anxiety who seek additional services tend to see a provider within two weeks
could subtly encourage families to move more quickly. This simple, low-cost method could
easily be randomized to enable administrative systems to learn more about their beneficiaries’
decision-making processes and the fiscal impact of encouraging pursuit of services.
Limitations of the current study should also be highlighted. First, youth were restrictively
selected to represent first known identification of a single diagnosis, which likely resulted in
discrepancies in the proportions of problem types (i.e., anxiety, depression, and disruptive
behavior) compared to what might otherwise be expected for clinical settings. Likewise, this
restrictive selection may limit generalizability to public health data when multiple comorbidities or recurrent episodes are considered. At the same time, this design strategy allowed a
direct examination of the initial treatment episode and ensured limited confounds in mapping
the reception of services over time. Additionally, the comparison of trends in service provision
to a known standard in the Child STEPs study were coarse at best, albeit reflective of the best
comparison data currently available. It is possible that patterns of services in the current data
did not match those seen in STEPs due to positive treatment outcomes being achieved in
much less time. It should be noted that this is unlikely, however, given limited previous evidence for positive outcome in treatment as usual [25,49,50]. Alternatively, there could be
numerous environmental explanations that are independent of the quality of services provided
(as outlined above). It was unfortunately not feasible to discern further details using administrative claims data, and more applied, organizational research will be necessary to understand
these issues. Future studies combining “big data” approaches and primary research methods
may address these limitations, advance integration of research and practice, and ultimately
inform healthcare policy.
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